Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$970M |
| 2 |
AbbVie
ABBV
|
+$554M |
| 3 |
IBM
IBM
|
+$535M |
| 4 |
TC Energy
TRP
|
+$489M |
| 5 |
McKesson
MCK
|
+$459M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.32B |
| 2 |
MON
Monsanto Co
MON
|
+$1.1B |
| 3 |
Kinder Morgan
KMI
|
+$684M |
| 4 |
Amgen
AMGN
|
+$670M |
| 5 |
Danaher
DHR
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.92% |
| 2 | Technology | 12.36% |
| 3 | Communication Services | 10.31% |
| 4 | Consumer Discretionary | 10.04% |
| 5 | Energy | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RRD
251
DELISTED
RR Donnelley & Sons Co.
RRD
| $135M | 0.04% |
+2,866,233
| New | +$147M |
|
|
TMH
252
DELISTED
Team Health Holdings Inc
TMH
| $135M | 0.04% |
4,144,270
-710,004
| -15% | -$26.2M |
|
253
Tesla
TSLA
$1.32T
| $134M | 0.04% |
9,856,500
-2,328,000
| -19% | -$33.6M |
|
254
Analog Devices
ADI
$188B
| $129M | 0.04% |
1,999,640
| – | – |
|
|
SBNY
255
DELISTED
Signature Bank
SBNY
| $126M | 0.04% |
1,066,559
| – | – |
|
256
Cable One
CABO
$194M
| $121M | 0.04% |
206,499
| – | – |
|
|
DNR
257
DELISTED
Denbury Resources, Inc.
DNR
| $120M | 0.04% |
37,158,795
| – | – |
|
258
Simon Property Group
SPG
$71.9B
| $119M | 0.04% |
575,002
| – | – |
|
259
Five Below
FIVE
$13.4B
| $111M | 0.04% |
2,757,120
+10,900
| +0.4% | +$504K |
|
260
Restaurant Brands International
QSR
$26.7B
| $110M | 0.04% |
2,464,773
-62,826
| -2% | -$2.85M |
|
261
Verisk Analytics
VRSK
$23.3B
| $110M | 0.04% |
1,349,300
| – | – |
|
262
Kemper
KMPR
$1.56B
| $109M | 0.04% |
2,784,000
| – | – |
|
263
Automatic Data Processing
ADP
$107B
| $109M | 0.04% |
1,238,592
-1,433
| -0.1% | -$130K |
|
264
Viavi Solutions
VIAV
$10.6B
| $108M | 0.04% |
14,664,274
-6,800,030
| -32% | -$49.8M |
|
|
MGP
265
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $104M | 0.03% |
3,985,249
| – | – |
|
266
Brinker International
EAT
$10.3B
| $103M | 0.03% |
2,041,500
+34,000
| +2% | +$1.71M |
|
267
Valmont Industries
VMI
$9.5B
| $102M | 0.03% |
759,000
| – | – |
|
|
CRAY
268
DELISTED
Cray, Inc.
CRAY
| $101M | 0.03% |
4,272,068
+289,081
| +7% | +$7.37M |
|
269
ABM Industries
ABM
$2.82B
| $100M | 0.03% |
2,523,000
+76,000
| +3% | +$2.89M |
|
270
Jefferies Financial Group
JEF
$12.6B
| $94.2M | 0.03% |
5,527,549
| – | – |
|
|
SWNC
271
DELISTED
Southwestern Energy Company
SWNC
| $92.2M | 0.03% |
2,921,233
+1,455,233
| +99% | +$46.9M |
|
272
American Electric Power
AEP
$68B
| $92.1M | 0.03% |
1,435,000
| – | – |
|
|
WP
273
DELISTED
Worldpay, Inc.
WP
| $91.8M | 0.03% |
+1,630,849
| New | +$90.6M |
|
274
Myriad Genetics
MYGN
$301M
| $91M | 0.03% |
4,423,358
-3,058,777
| -41% | -$77.6M |
|
|
DCUC
275
DELISTED
Dominion Energy, Inc.
DCUC
| $89.6M | 0.03% |
1,800,000
| – | – |
|
Similar funds
Capital Research Global Investors's Q3 2016 Portfolio in Review
As of Q3 2016, Capital Research Global Investors held 443 positions worth $303B, up 3.4% from $292B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Capital Research Global Investors's Q3 2016 filing shows 24 new, 126 increased, 140 reduced and 30 closed positions. Its largest new stake was TC Energy: 10,475,000 shares worth $498M. The largest sale was Alexion Pharmaceuticals, an estimated $1.32B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q3 2016 buy was TC Energy: 10,475,000 shares worth $498M.
- Capital Research Global Investors added most to ExxonMobil in Q3 2016, an estimated $970M increase.
- Capital Research Global Investors's biggest Q3 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.32B.
- Capital Research Global Investors fully exited Waste Management in Q3 2016, selling an estimated $637M.
- Capital Research Global Investors's ten largest holdings make up 25% of its $303B portfolio in Q3 2016.
- Capital Research Global Investors opened 24 new positions and closed 30 in Q3 2016.
- Capital Research Global Investors's portfolio value rose 3.4% quarter-over-quarter to $303B.
Based on Capital Research Global Investors's 13F filing for Q3 2016, filed 14 Nov 2016.